You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR IMODIUM A-D EZ CHEWS

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for IMODIUM A-D EZ CHEWS

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00075868 ↗	Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer	Completed	National Cancer Institute (NCI)	Phase 3	2003-12-01	RATIONALE: Octreotide may be effective in preventing or controlling diarrhea in patients who are undergoing chemoradiotherapy for anal or rectal cancer. It is not yet known whether octreotide is effective in treating diarrhea. PURPOSE: This randomized phase III trial is studying octreotide in preventing or reducing diarrhea in patients who are undergoing chemoradiotherapy for anal or rectal cancer.
NCT00075868 ↗	Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer	Completed	Radiation Therapy Oncology Group	Phase 3	2003-12-01	RATIONALE: Octreotide may be effective in preventing or controlling diarrhea in patients who are undergoing chemoradiotherapy for anal or rectal cancer. It is not yet known whether octreotide is effective in treating diarrhea. PURPOSE: This randomized phase III trial is studying octreotide in preventing or reducing diarrhea in patients who are undergoing chemoradiotherapy for anal or rectal cancer.
NCT00292344 ↗	Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea	Completed	Bausch Health Americas, Inc.	Phase 4	2004-06-01	Most cases of travelers' diarrhea are caused by bacterial pathogens which respond slowly to antibiotic treatment.The study was designed to determine the value of rapidly acting loperamide (imodium) combined with curative dose of the poorly absorbed rifaximin in travelers' diarreha treatment.
NCT00292344 ↗	Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea	Completed	Valeant Pharmaceuticals International, Inc.	Phase 4	2004-06-01	Most cases of travelers' diarrhea are caused by bacterial pathogens which respond slowly to antibiotic treatment.The study was designed to determine the value of rapidly acting loperamide (imodium) combined with curative dose of the poorly absorbed rifaximin in travelers' diarreha treatment.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for IMODIUM A-D EZ CHEWS

Condition Name

Chart
Table

Condition Name for IMODIUM A-D EZ CHEWS
Intervention	Trials
Diarrhea	5
Fecal Incontinence	3
Travelers' Diarrhea	2
Healthy	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for IMODIUM A-D EZ CHEWS
Intervention	Trials
Diarrhea	10
Fecal Incontinence	3
Rectal Neoplasms	2
Dysentery	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for IMODIUM A-D EZ CHEWS

Trials by Country

Map
Table

Trials by Country for IMODIUM A-D EZ CHEWS
Location	Trials
United States	59
Mexico	6
Spain	3
United Kingdom	1
Russian Federation	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for IMODIUM A-D EZ CHEWS
Location	Trials
California	5
Texas	5
North Carolina	4
Alabama	2
Washington	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for IMODIUM A-D EZ CHEWS

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for IMODIUM A-D EZ CHEWS
Clinical Trial Phase	Trials
Phase 4	6
Phase 3	3
Phase 2/Phase 3	1
[disabled in preview]	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for IMODIUM A-D EZ CHEWS
Clinical Trial Phase	Trials
Completed	12
Terminated	5
Withdrawn	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for IMODIUM A-D EZ CHEWS

Sponsor Name

Chart
Table

Sponsor Name for IMODIUM A-D EZ CHEWS
Sponsor	Trials
M.D. Anderson Cancer Center	2
Johnson & Johnson Consumer and Personal Products Worldwide	2
McNeil AB	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for IMODIUM A-D EZ CHEWS
Sponsor	Trials
Other	29
Industry	18
U.S. Fed	4
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.